Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pharmavite

This article was originally published in The Tan Sheet

Executive Summary

Naturmade Essentials relaunch will be backed by TV ads in the fourth quarter, while print ads continue. The line is being rebranded to combine all Nature Made multivitamins and add four multi/herbal combos: gingko biloba, kava kava, ginseng and garlic & soy (1"The Tan Sheet" Jan. 24, p. 14). The company's new double-strength SAMe 400 mg is more effective than doubling the dose of its original SAMe 200 mg, Pharmavite says. The extension is sold in 12- and 30-count bottles and is priced the same as the 20- and 50-counts of the smaller dosage product. The 20-count 200 mg SAMe will be available with a 10-count trial size of Super B Complex or a special 24-count bottle for the same price. A $2.5 mil. print ad spend follows a $4 mil. TV campaign in March and April and complements a $900,000 PR spend and $2 mil. budgeted for detailing. Pharmavite has also relaunched CalBurst calcium chews with improved chocolate flavor and new vanilla
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS091384

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel